# Hydroxychloroquine in ANCA Vasculitis Evaluation

> **NCT04316494** · PHASE4 · TERMINATED · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 43 (actual)

## Conditions studied

- ANCA Associated Vasculitis
- Microscopic Polyangiitis
- Churg-Strauss Syndrome
- Wegener Granulomatosis

## Interventions

- **DRUG:** Hydroxychloroquine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04316494
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-12-17
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-05-15
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** Recruitment was terminated early by the funder due to study sites' inability to recruit sufficient number of participants.
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316494, "Hydroxychloroquine in ANCA Vasculitis Evaluation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04316494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*